CCND1 and neoplasm: Therefore, we hypothesised that the genome status of CCND1 in primary oesophageal cancer could be predictable by a less invasive, blood-based test, which enable to evaluate primary tumour dynamics and predict prognosis and associated clinicopathological factors.